Previous 10 | Next 10 |
The following slide deck was published by Meridian Bioscience, Inc. in conjunction with this event. For further details see: Meridian Bioscience (VIVO) Presents 23rd Annual Global Investment Virtual Conference - Slideshow
CINCINNATI, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the addition of two new Air-Dryable™ Master Mixes with the launch of its Air-Dryable™ Direct DNA ...
CINCINNATI, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new Air-Dryable™ Direct DNA qPCR Saliva and Air-Dryable™ Direct RNA/DNA qPCR Sa...
CINCINNATI, OH / ACCESSWIRE / September 1, 2021 / Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. ("Magellan"), expanded the Class I recall of its LeadC...
CINCINNATI, OH / ACCESSWIRE / August 30, 2021 / Meridian Bioscience, Inc. (NASDAQ:VIVO), a provider of diagnostic testing solutions and life science raw materials, announced today its participation in the H. C. Wainwright 23rd Annual Global Investment Conference. Jack Kenny, Chief Executive ...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. About XLV. A list of cheap stocks. For further details see: XLV: Healthcare Dashboard For August
Image source: The Motley Fool. Meridian Bioscience Inc (NASDAQ: VIVO) Q3 2021 Earnings Call Aug 6, 2021 , 10:00 a.m. ET Operator Continue reading For further details see: Meridian Bioscience Inc (VIVO) Q3 2021 Earnings Call Transcript
Meridian Bioscience, Inc. (VIVO) Q3 2021 Earnings Conference Call August 06, 2021 10:00 AM ET Company Participants Charles Wood - Vice President of Corporate Strategy, Business Development and Investor Relations John Kenny - Chief Executive Officer Bryan Baldasare - Executive Vice President a...
The following slide deck was published by Meridian Bioscience, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Meridian Bioscience, Inc. 2021 Q3 - Results - Earnings Call Presentation
Meridian Bioscience (NASDAQ:VIVO): FQ3 Non-GAAP EPS of $0.22 misses by $0.09; GAAP EPS of $0.27 misses by $0.05. Revenue of $63.51M (-25.1% Y/Y) misses by $9.61M. Press Release For further details see: Meridian Bioscience EPS misses by $0.09, misses on revenue
News, Short Squeeze, Breakout and More Instantly...
Meridian Bioscience Inc. Company Name:
VIVO Stock Symbol:
NASDAQ Market:
Meridian Bioscience Inc. Website:
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...
Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that it has obtained a final court order (the " Final Order ") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced pl...
Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that, at the special meeting of the shareholders of VIVO (the " Shareholders ") held today (the " Meeting "), the Shareholders approved (i) a special resolutio...